Sensory neuropathies are frequently associated with diabetes or with antimitotic treatments in humans suffering from cancer, and are in this case the most important limitation to the use of antimitotic drugs. For this reason, there is a need to establish and validate animal models of sensory neuropathies that could be routinely used, together with the already known models, for studying and evaluating the effects of putative neuroprotective compounds. In the present study, we prove by behavioral and electromyographical analyses that (a) it is possible to induce a nonlethal, exclusively sensory, reversible neuropathy by intoxicating rats with large amounts of pyridoxine, using a new schedule of intoxication; (b) 4-methylcatechol, a drug known to induce nerve growth factor synthesis, improves the clinical status of pyridoxine-intoxicated animals, shortens the duration of the disease, and restores the morphological integrity of the sensory fibers. Owing to its mode of installation and its clinical features, we propose that this model be used as an additional model for preclinical studies of neuroprotective drugs.
INTRODUCTION
Peripheral neuropathies are characterized by motor, sensory, and sympathetic deficits. Sensory neuropathies are frequently associated with diabetes or antimiototic treatments-such as taxol or cisplatin-of patients suffering from cancers (Chaudry et al., 1994) , and in this case are the most important limitation to the use of these drugs. They also frequently accompany vitamin deficiency, hypothyroidism, uremia, and characterize inherited neuropathies with recognized metabolic disorders.
Owing to the likely very different molecular pathogeneses of these neuropathies, there is a need to enrich the palette of animal models of sensory neuropathies usable for preclinical studies of putative neuroprotective compounds. The main problem in development of experimentally induced sensory neuropathies are the side effects of the inducing treatment-such as nephrotoxicity for cisplatin, cardiotoxicity for taxol, or simultaneous injury of motor and sensory fibers for acrylamide (Fullerton and Barnes, 1966; Hopkins et al., 1971 )-which are often predominant and hide the sensory neuropathy properly said.
The model described here is based on clinical observations of (a) human patients who displayed a neuropathy affecting large fibers with severe loss of proprioceptive sensitivity, after being overdosed with vitamine B6 (pyridoxine) (Schaumburg et al., 1983; Albin 
